Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bacterial Toxin Sets the Course for Infection

By LabMedica International staff writers
Posted on 21 Nov 2013
Various toxins and effector proteins of bacterial pathogens have been found to manipulate eukaryotic cell machineries to promote persistence and proliferation within their hosts.

Some isolates of Yersinia pseudotuberculosis produce the cytotoxic necrotizing factor (CNFγ), but the functional consequences of this toxin for host-pathogen interactions during the infection are unknown.

Scientists at Helmholtz Center for Infection Research (Brunswick, Germany) cultured Yersinia strains in Luria-Bertani (LB) broth at 25 °C or 37 °C. More...
All DNA manipulations, polymerase chain reactions, restriction digestions, ligations, and transformations were performed using standard techniques. The β-galactosidase activity was determined for three independent cultures of bacteria.

Activation of Ras homolog gene family, member A (RhoA) was tested using the Rho activation assay kit (Millipore; Billerica, MA, USA) and activation of ras-related C3 botulinum toxin substrate 1 (Rac1) and cell division control protein 42 homolog (Cdc42) was determined with the Rho/Rac/Cdc42 Activation Assay Combo Kit (Cell Biolabs; San Diego, CA, USA).

In order to elucidate its function, the scientists genetically modified a bacterial strain that usually forms CNFγ in such a way that it lost the ability to produce this factor. They identified the molecular target that CNFγ manipulates, generating the dramatic consequences that involve the so-called small Rho guanosine triphosphate enzymes (GTPases). These enzymes initiate a whole cascade of events, for example alteration of the cytoskeleton. This leads to pores in the host cell surface, through which bacterial syringes can more efficiently transport active agents into the cell. The observed cell mortality of the immune cells is introduced through Rho GTPases as well.

Petra Dersch, PhD, a professor and senior author of the study explained, “We have discovered a very clever strategy of Yersinia pseudotuberculosis. With the aid of CNFγ, the bacterium manipulates the host cell in such a manner that the injection apparatus can work more effectively. It sets the course for an efficient infection and triggers onset of the disease.” The authors concluded that CNFγ is important for pathogenicity by showing that this toxin modulates inflammatory responses, protects the bacteria from attacks of innate immune effectors and enhances the severity of a Yersinia infection. The study was published on November 7, 2013, in the journal Public Library of Science Pathogens.

Related Links:

Helmholtz Centre for Infection Research
Millipore 
Cell Biolabs 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Clinical Informatics Platform
CLARION™
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.